E-Book, Englisch, 369 Seiten, eBook
Reihe: Contemporary Cardiology
Lincoff Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease
1999
ISBN: 978-1-59259-724-6
Verlag: Humana Press
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 369 Seiten, eBook
Reihe: Contemporary Cardiology
ISBN: 978-1-59259-724-6
Verlag: Humana Press
Format: PDF
Kopierschutz: 1 - PDF Watermark
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Weitere Infos & Material
Part I. Basic Principles. Thrombosis in Acute Coronary Syndromes and Coronary Interventions, Thaddeus R. Tolleson and Robert A. Harrington. Mechanisms of Platelet Adhesion, Edward F. Plow. Glycoprotein IIb/IIIa in Platelet Aggregation and Acute Arterial Thrombosis, Debbie A. Law and David R. Phillips. Glycoprotein IIb/IIIa Antagonists: Development of Abciximab and Pharmacology of Select Agents. Barry S. Coller Part II. Glycoprotein IIb/IIIa Blockade During Coronary Intervention. Abciximab in Coronary Intervention: The EPIC, EPILOG, EPISTENT Trials, A. Michael Lincoff. Eptifibatide in Coronary Intervention: The IMPACT Trials, Conor O'Shea and James E. Tcheng. Tirofiban in Coronary Intervention: The RESTORE Trial, Mohamed Y. Salame, Spencer B. King III, and Nicolas A. Chronos. Use of Abciximab in Therapy-Resistant Unstable Angina: Clinical and Angiographic Results of the CAPTURE Pilot and the CAPTURE Study, Marcel J. B. M. van den Brand and Maarten L. Simoons. Overview of the Glycoprotein IIb/IIIa Interventional Trials, A. Michael Lincoff and Eric J. Topol. Part III. Glycoprotein IIb/IIIa Blockade for Acute Ischemic Syndromes. Unstable Angina: PURSUIT, PARAGON, PRISM, and PRISM Plus, David J. Moliterno and Harvey D. White. The Use of Glycoprotein IIb/IIIa in Acute Myocardial Infarction, Adam B. Greenbaum, Robert A. Harrington, and E. Magnus Ohman. Part IV. Practical Issues and Future Applications. Economics of Glycoprotein IIb/IIIa Inhibition, Daniel B. Mark. Monitoring Platelet Aggregation, Neal S. Kleiman, Wojciech Mazur, and Nikki Graziadei. Oral Platelet Glycoprotein IIb/IIIa Blockade, Dean J. Kereiakes and Christopher P. Cannon. Cerebrovascular Aspects of Glycoprotein IIb/IIIa Inhibitors, Cathy A. Sila. The Future of Glycoprotein IIb/IIIa Inhibitors, Robert M. Califf and David F. Kong.
